The Bottlenecked GPU: How Medical Debt Stalls Healthcare Revolution

It is 3:00 AM. My pager vibrates with the familiar summons to the ED for yet another syncope admission. As a hospitalist, these encounters have become a scripted routine. “What brings you in?” “Did you lose consciousness?” These questions form the backbone of a mundane interview as I assess the nature of their symptoms. I […]

The Bottlenecked GPU: How Medical Debt Stalls Healthcare Revolution Read More »

Dupilumab in COPD: Using AEC as a Biomarker to Break the Hospitalization Cycle

The 2 AM Reality It is 2 AM at the hospital. I am processing an admission for “Mr. B,” a 70 year old with COPD. This is his second admission of 2026, and March has just begun. Mr. B is the “Gold Standard” failure: he is adherent to triple therapy (ICS/LAMA/LABA) and uses his rescue

Dupilumab in COPD: Using AEC as a Biomarker to Break the Hospitalization Cycle Read More »